Function
Locations
P450 that removes lanosterol's 14-alpha-methyl group (three oxidative steps), the first post-lanosterol demethylation.
The post-lanosterol segment of cholesterol biosynthesis converts lanosterol into cholesterol through a ~19-reaction sequence of demethylations, isomerisation, desaturations and reductions carried out by endoplasmic-reticulum-membrane enzymes. The three lanosterol methyl groups are removed first: CYP51A1 (a cytochrome P450) removes the 14-alpha-methyl group; then the two C4 methyls are removed in two rounds by the C4- demethylation machinery in which MSMO1 (a non-heme di-iron methylsterol oxidase) oxidises the C4 methyl to a carboxylate and NSDHL (a 3-beta-hydroxysteroid dehydrogenase/ C4-decarboxylase) decarboxylates it (a 3-ketoreductase then restores the 3-beta-ol). EBP (sterol Delta(8)-Delta(7) isomerase) shifts the ring double bond from Delta8 to Delta7; SC5D (lathosterol oxidase / sterol-C5-desaturase) introduces the C5-6 double bond; and DHCR7 (7-dehydrocholesterol reductase) reduces the C7-8 double bond to give cholesterol. The pathway runs as two interconvertible arms — the Bloch arm (retaining the side-chain Delta24 double bond until the end) and the Kandutsch-Russell arm (in which DHCR24 reduces the Delta24 bond early) — that differ only in the timing of the DHCR24 step. Inherited enzyme defects cause distinctive malformation/skeletal/skin disorders: DHCR7 -> Smith-Lemli-Opitz syndrome; SC5D -> lathosterolosis; EBP -> X-linked chondrodysplasia punctata 2 (Conradi-Hunermann-Happle); NSDHL -> CHILD syndrome; MSMO1 -> SC4MOL deficiency; and DHCR24 -> desmosterolosis.
All recommended fields populated.
✗ none found
No MODULE:cholesterol_synthesis_post_lanosterol deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
6 complete review(s) · 0 with deep research · 0 missing review · 6 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| CYP51A1 Q16850 | ✓ | ✓ | ✗ |
| DHCR7 Q9UBM7 | ✓ | ✓ | ✗ |
| EBP Q15125 | ✓ | ✓ | ✗ |
| MSMO1 Q15800 | ✓ | ✓ | ✗ |
| NSDHL Q15738 | ✓ | ✓ | ✗ |
| SC5D O75845 | ✓ | ✓ | ✗ |
The post-lanosterol segment of cholesterol biosynthesis grounded to the human enzymes CYP51A1 (UniProtKB:Q16850, GO:0008398, EC 1.14.14.154), MSMO1 (Q15800, GO:0000254, EC 1.14.18.9), NSDHL (Q15738, GO:0000252), EBP (Q15125, GO:0000247, EC 5.3.3.5), SC5D (O75845, GO:0050046, EC 1.14.19.20) and DHCR7 (Q9UBM7, GO:0047598, EC 1.3.1.21). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each step uses a PANTHER family selector with the human enzyme as representative (MSMO1 and SC5D share the fatty-acid- hydroxylase/sterol-desaturase family PTHR11863). This is a SIMPLIFIED ordered view of a ~19-reaction, branched segment: it runs as two interconvertible arms — the Bloch arm (the side-chain Delta24 bond is kept until the end) and the Kandutsch-Russell arm (DHCR24 reduces Delta24 early) — differing only in when DHCR24 (UniProtKB:Q15392, GO:0000246 Delta24-sterol reductase; reviewed previously, on main, deficiency = desmosterolosis) acts; intervening C14- and 3-keto-reductase steps (e.g. by LBR/TM7SF2 and HSD17B7) are abbreviated. Upstream, lanosterol comes from the sterol_commitment_squalene_to_lanosterol module (FDFT1/SQLE/LSS); the immediate substrate lanosterol is made by the mevalonate -> squalene route. Disorders map to individual steps: CYP51A1 (no common disease), MSMO1 (SC4MOL deficiency), NSDHL (CHILD/CK syndrome), EBP (CDPX2 / Conradi-Hunermann-Happle), SC5D (lathosterolosis), DHCR7 (Smith-Lemli-Opitz syndrome), DHCR24 (desmosterolosis).
P450 that removes lanosterol's 14-alpha-methyl group (three oxidative steps), the first post-lanosterol demethylation.
Non-heme di-iron oxidase oxidising the sterol C4-methyl group to a carboxylate (repeated for both C4 methyls); the oxidative part of C4-demethylation. MSMO1 deficiency = SC4MOL deficiency.
NAD(P)+-dependent 3-dehydrogenation/decarboxylation of the 4-carboxysterol; the decarboxylating half of C4-demethylation. NSDHL deficiency = CHILD / CK syndrome.
Shifts the ring double bond from Delta8 to Delta7. Deficiency = X-linked chondrodysplasia punctata 2 (Conradi-Hunermann-Happle).
Introduces the C5-6 double bond (lathosterol -> 7-dehydrocholesterol). Deficiency = lathosterolosis.
Reduces the C7-8 double bond of 7-dehydrocholesterol to give cholesterol (and, in the Bloch arm, 7-dehydrodesmosterol -> desmosterol); 7-DHC is also the vitamin-D3 precursor. Deficiency = Smith-Lemli-Opitz syndrome.